Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
Clinical trial NCT07457359 · RECRUITING
Trial details
- NCT number
- NCT07457359
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-04
- Primary completion
- 2028-01-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.